NEKTAR THERAPEUTICS (NKTR)

US6402681083 - Common Stock

1.38  -0.04 (-2.82%)

After market: 1.3438 -0.04 (-2.62%)

Buy % Consensus

47

ChartMill assigns a Buy % Consensus number of 47% to NKTR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 2.04. This target is 47.83% above the current price.
NKTR was analyzed by 9 analysts. The buy percentage consensus is at 47. So analysts seem to be rather neutral about NKTR.
In the previous month the buy percentage consensus was at a similar level.
NKTR was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 1.381.012.042.043.15 - -26.81% 47.83% 47.83% 128.26%
Up and Down Grades
Date Firm Action Rating
2024-03-06 Jefferies Maintains Hold -> Hold
2023-11-20 JP Morgan Reiterate Underweight
2023-11-09 TD Cowen Upgrade Market Perform -> Outperform
2023-08-07 Mizuho Reiterate Neutral
2023-05-10 Jefferies Upgrade Underperform -> Hold
2023-03-06 Oppenheimer Maintains Perform
2023-02-27 Goldman Sachs Maintains Sell
2023-02-24 SVB Leerink Maintains Market Perform
2023-02-24 Jefferies Downgrade Hold -> Underperform
2022-08-08 JP Morgan Downgrade Neutral -> Underweight
2022-04-18 Mizuho Maintains Neutral
2022-04-18 SVB Leerink Maintains Market Perform
2022-04-18 Goldman Sachs Downgrade Neutral -> Sell
2022-03-09 Oppenheimer Upgrade Perform -> Outperform
2021-11-08 Benchmark Upgrade Hold -> Buy
2021-11-08 SVB Leerink Maintains Market Perform
2021-11-05 Oppenheimer Maintains Perform
2021-09-10 B of A Securities Initiate Neutral
2021-08-06 SVB Leerink Maintains Market Perform
2021-06-28 Stifel Upgrade Hold -> Buy
2021-05-10 SVB Leerink Maintains Market Perform
2021-04-06 SVB Leerink Maintains Market Perform
2021-02-22 Benchmark Downgrade Buy -> Hold